Nevro, Globus
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain,
3h
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...
Montgomery County's Globus Medical has agreed to acquire a California life sciences company focused on treating chronic pain ...
On a stand-alone basis, Globus Medical (GMED) reaffirms guidance for 2025 net sales of $2.66B to $2.69B and fully diluted non-GAAP earnings per ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Labcorp Holdings (LH – Research Report), ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
you should consider Globus Medical (GMED). This company, which is in the Zacks Medical - Instruments industry, shows potential for another earnings beat. This medical device company has seen a ...
Stock analysts at Roth Capital dropped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a ...
Stifel analysts maintained a Buy rating and a $92.00 price target for Globus Medical (NYSE:GMED) stock following the company's announcement of acquiring Nevro Corp . (NYSE:NVRO) for an equity value of ...
Fintel reports that on January 9, 2025, B of A Securities upgraded their outlook for Globus Medical (NYSE:GMED) from Underperform to Neutral. As of December 24, 2024, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback